Review
Aug 2026
Emerging CAR-T Cell Therapies for T Cell Malignancies: Innovations, Challenges, and Future Directions
Continued efforts to identify highly specific target antigens, optimize manufacturing processes, enhance safety, and integrate CAR-T therapy with complementary immunotherapeutic approaches are expected to improve clinical outcomes and broaden the application of CAR-T therapy to T-cell malignancies and potentially other solid and hematologic cancers.
H. Hetta, Fawaz E Alanazi, Mahmoud H. El-Maghrabey et al.
· Journal of Pharmaceutical In... · 0 citations